| Literature DB >> 29850220 |
Katarzyna Krysik1, Ewa Wroblewska-Czajka2, Anita Lyssek-Boron1, Edward A Wylegala2,3,4, Dariusz Dobrowolski1,2,3.
Abstract
PURPOSE: Evaluation of the indications, anatomical and functional results, and complications of total penetrating keratoplasty (TPK) in disorders involving whole cornea.Entities:
Year: 2018 PMID: 29850220 PMCID: PMC5933013 DOI: 10.1155/2018/9580292
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1Transparent graft.
Causes of the corneal tissue destruction and perforation (% in brackets).
| Cause of perforation | Total ( | Female ( | Male ( |
|---|---|---|---|
|
| 22 (46.8) | 11 (23.4) | 11 (23.4) |
| Bacterial | 13 (27.6) | 6 (10.6) | 7 (17) |
| Fungal | 7 (14.9) | 4 (8.5) | 3 (6.3) |
| Protozoal | 2 (4.25) | 1 (2.1) | 1 (2.1) |
|
| 10 (21.3) | 6 (12.8) | 4 (8.5) |
|
| 12 (25.5) | 4 (8.5) | 8 (17) |
| Chemical (burns) | 8 (17) | 3 (6.3) | 5 (10.6) |
| Penetrating | 4 (8.5) | 1 (2.1) | 3 (6.3) |
|
| 3 (6.3) | 1 (2.1) | 2 (4.25) |
Repeated surgical tectonic treatment after primary TPK (% in brackets).
| Characteristics | Total ( | Females ( | Males ( |
|---|---|---|---|
| Regrafts rate | |||
| reTPK | 17 (58.6) | 7 (53.8) | 10 (62.5) |
| PK | 8 (27.6) | 5 (38.5) | 3 (18.75) |
| CSPG | 4 (13.8) | 1 (7.7) | 3 (18.75) |
BSCVA after total penetrating keratoplasty and successive optical surgical procedures.
| Characteristics | Total | Preoperative BSCVA (range) | Postoperative BSCVA (range) |
|---|---|---|---|
|
| |||
| PK | 4 | LP–0.02 | CF–0.1 |
| PK + cataract surgery + PCIOL implantation | 3 | LP–0.01 | 0.05–0.2 |
| Cataract surgery + PCIOL implantation | 2 | HM–0.01 | 0.05–0.2 |
| Secondary PCIOL in-sulcus implantation | 1 | 0.02 | 0.2 |
| Transscleral IOL fixation | 1 | 0.02 | 0.1 |
CF: counting fingers; HM: hand movements.
Figure 2Partially transparent graft.
Figure 3Totally opaque graft.
Postoperative complications of total penetrating keratoplasty (% in brackets).
| Primary cause of ocular disease | Infection Total | Autoimmune Total | Trauma Total | Other Total |
|---|---|---|---|---|
|
| ||||
| Persistent epithelial defect | 13 (59.1) | 9 (90) | 9 (75) | 3 (100) |
| Reinfection | 15 (68.2) | 3 (30) | 1 (8.3) | 0 |
| Graft melting | 8 (36.4) | 7 (70) | 2 (16.7) | 0 |
| Graft rejection | 5 (100) | 0 | 0 | 0 |
| Glaucoma or ocular hypertension | 4 (18.2) | 4 (40) | 6 (50) | 1 (33.3) |